Axel Van Rozenberg, Executive Vice President of Operations of the World Bank, said on the 9th that the World Bank intends to raise US$2 billion by the end of April to help approximately 40 developing countries and regions obtain the new crown vaccine.
During the 2021 IMF and World Bank spring meeting on the new crown vaccine, Van Rozenberg said: “The World Bank Group is committed to raising US$2 billion by the end of April to help more than one in vaccine procurement, research and development, and production. 40 (developing) countries and regions.”
World Bank President David Malpass said in his speech that the World Bank expects to expand the above-mentioned funding to US$4 billion by the middle of this year, benefiting approximately 50 countries and regions.
The funds raised by the World Bank will be used for the New Coronary Pneumonia Vaccine Implementation Plan (COVAX), a global acquisition mechanism for the new crown vaccine. The Global Alliance for Vaccines and Immunization, which leads the COVAX mechanism, and the World Health Organization stated in a statement on the 8th that COVAX has distributed nearly 38.4 million doses of the new crown vaccine to more than 100 countries and regions.
